Chevy Chase, MD, United States of America

Masaru Kanekiyo

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Chevy Chase, MD (US) (2018 - 2024)
  • North Bethesda, MD (US) (2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Unveiling the Innovations of Inventor Masaru Kanekiyo

Introduction: Masaru Kanekiyo, a prolific inventor based in Chevy Chase, MD, has made significant contributions in the field of vaccines and viral infections. With an impressive track record of 20 patents, his latest inventions focus on developing vaccines that elicit broadly protective anti-influenza antibodies and prefusion coronavirus spike proteins.

Latest Patents:

1. Stabilized influenza hemagglutinin stem region trimers and uses thereof: These innovative vaccines comprise nanoparticles displaying HA trimers from the influenza virus on their surface. The fusion proteins self-assemble, generating HA-displaying nanoparticles that specifically target the stem region of an influenza HA protein.

2. Prefusion coronavirus spike proteins and their use: Kanekiyo's patents introduce coronavirus S ectodomain trimers stabilized in a prefusion conformation. These proteins, along with nucleic acid molecules and vectors encoding them, serve as potent tools in generating immune responses and treating or preventing coronavirus infections.

Career Highlights:

Masaru Kanekiyo has left a remarkable imprint on the field of bioengineering and virology through his research and patent portfolio. Notably, he has worked with prestigious institutions such as The United States of America, represented by the Department of Health and Human Services, and The Scripps Research Institute.

Collaborations:

Kanekiyo's innovative endeavors have been further enriched by collaborations with accomplished colleagues such as Barney S Graham and Jeffrey C Boyington. Together, they have propelled advancements in vaccine development and antiviral strategies.

Conclusion:

In conclusion, Inventor Masaru Kanekiyo's dedication to pioneering groundbreaking solutions in the realm of vaccines and viral infections is truly commendable. His latest patents underscore his commitment to enhancing global health and combating infectious diseases. We eagerly anticipate the future innovations that will undoubtedly emerge from his inventive prowess.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…